These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26235888)

  • 1. Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
    Perrottet N; Steinrücken J; Chan M; Pannatier A; Borens O; Yusuf E; Trampuz A
    Int J Antimicrob Agents; 2015 Oct; 46(4):480-2. PubMed ID: 26235888
    [No Abstract]   [Full Text] [Related]  

  • 2. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy.
    Yuste JR; Quesada M; Díaz-Rada P; Del Pozo JL
    Int J Infect Dis; 2014 Oct; 27():65-6. PubMed ID: 25192907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections.
    Slim J; Jimenez H; Culshaw D; Patel H; Lamp KC
    J Int Assoc Provid AIDS Care; 2015; 14(3):202-6. PubMed ID: 25320146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.
    Knapp AG; Kamepalli RK; Martone WJ; Yankelev S
    Surg Infect (Larchmt); 2011 Apr; 12(2):113-8. PubMed ID: 21348765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of daptomycin for the treatment of Gram-positive bacterial infections in Chinese population].
    Zhang L; Li J; Wan X; Shen J; Liu H; Gao H; Liu Z; Wang A
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):496-500. PubMed ID: 26359009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observation of the efficacy and safety of daptomycin in the treatment of agranulocytosis complicated by Gram-positive bacteria infections].
    Wang H; Liu H; Zhou L; Lin ZH; Xu RR; You XF
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1065-7. PubMed ID: 24369168
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
    Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
    Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
    Corona Pérez-Cardona PS; Barro Ojeda V; Rodriguez Pardo D; Pigrau Serrallach C; Guerra Farfán E; Amat Mateu C; Flores Sanchez X
    J Antimicrob Chemother; 2012 Jul; 67(7):1749-54. PubMed ID: 22511636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin in paediatrics: current knowledge and the need for future research.
    Principi N; Caironi M; Venturini F; Pani L; Esposito S
    J Antimicrob Chemother; 2015 Mar; 70(3):643-8. PubMed ID: 25406298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18095389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration interval and daptomycin toxicity: a case report of rhabdomyolysis.
    Sbrana F; Di Paolo A; Pasanisi EM; Tagliaferri E; Arvia C; Puntoni M; Leonildi A; Bigazzi F; Danesi R; Rovai D; Tascini C; Menichetti F
    J Chemother; 2010 Dec; 22(6):434-5. PubMed ID: 21303756
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections.
    Stone PA; Armstrong PA; Bandyk DF; Brumberg RS; Flaherty SK; Back MR; Johnson BL; Shames ML
    J Vasc Surg; 2006 Oct; 44(4):757-61. PubMed ID: 17012000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cSSTIs: the role of daptomycin.
    Garau J
    Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early experience with high-dosage daptomycin for prosthetic infections.
    De Rosa FG; Mollaretti O; Cometto C; Pagani N; Montrucchio C; Di Perri G
    Clin Infect Dis; 2009 Dec; 49(11):1772-3. PubMed ID: 19891570
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.